Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Current Assets
Cash and cash equivalents	$ 7,965	$ 6,092
Short-term investments	899	2,406
Accounts receivable (net of allowance for doubtful accounts of $119 in 2018 and $159 in 2017)	7,071	6,873
Inventories (excludes inventories of $1,417 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	5,440	5,096
Other current assets	4,500	4,299
Total current assets	25,875	24,766
Investments	6,233	12,125
Property, Plant and Equipment (at cost)
Land	333	365
Buildings	11,486	11,726
Machinery, equipment and office furnishings	14,441	14,649
Construction in progress	3,355	2,301
Property, plant and equipment (at cost)	29,615	29,041
Less: accumulated depreciation	16,324	16,602
Property, plant and equipment, net	13,291	12,439
Goodwill	18,253	18,284
Other Intangibles, Net	11,431	14,183
Other Assets	7,554	6,075
Total Assets	82,637	87,872
Current Liabilities
Loans payable and current portion of long-term debt	5,308	3,057
Trade accounts payable	3,318	3,102
Accrued and other current liabilities	10,151	10,427
Income taxes payable	1,971	708
Dividends payable	1,458	1,320
Total current liabilities	22,206	18,614
Long-Term Debt	19,806	21,353
Deferred Income Taxes	1,702	2,219
Other Noncurrent Liabilities	12,041	11,117
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	1,788	1,788
Other paid-in capital	38,808	39,902
Retained earnings	42,579	41,350
Accumulated other comprehensive loss	(5,545)	(4,910)
Stockholders' equity before deduction for treasury stock	77,630	78,130
Less treasury stock, at cost: 984,543,979 shares in 2018 and 880,491,914 shares in 2017	50,929	43,794
Total Merck & Co., Inc. stockholders’ equity	26,701	34,336
Noncontrolling Interests	181	233
Total equity	26,882	34,569
Total Liabilities and Equity	$ 82,637	$ 87,872